Skip to main content

Cultivating Passion for Innovation and Connection: BioHouston CEO Ann Tanabe

Published Nov 05, 2020 by Lou Ann Duvall

Ann BioHouston

The global life science community is coming together for a virtual event next week that will explore the latest advances within the industry. The Texas Life Science Forum brings together industry professionals, emerging life science companies, academics, investors and thought leaders. The event is co-hosted by Rice University and BioHouston, a nonprofit organization founded by Houston-area academic and research institutions. Their mission is to generate economic wealth for Houston by establishing the region as a global competitor in life science and biotechnology commercialization. 

Ann Tanabe, BioHouston's CEO, said she has a passion for working with innovators. Earlier in her career, Tanabe worked in investor relations with publicly traded companies, including energy and pharmaceuticals. She joined BioHouston nine years ago. 

"Our work benefits the community by advancing the life sciences industry in Houston," said Tanabe. "We serve to connect scientists, intellectual property and product development experts, venture capitalists, pharmaceutical companies and life sciences entrepreneurs."

We asked Tanabe about how BioHouston drives life science innovation forward by connecting people to resources, talent and information. 

How have you seen the life sciences ecosystem in Houston change over the last few years? 

We are fortunate to be in the Texas Medical Center, with its academic and research work that revolves around innovation. More people are recognizing Houston for its opportunities to work in a broad range of life sciences roles. Bright young people are choosing to come to Houston for its great academic institutions, and they’re staying after graduation because they see opportunities to be game-changers in the life sciences arena. 

It’s a capital-intensive industry, and investors want to see that strong ecosystem and talent. They’re taking notice of what’s happening here. To have a fully-rounded ecosystem, you need companies at every point along the spectrum: start-ups, clinical stage, and industry veterans. We have all of that. 

What has BioHouston’s role been in the evolving ecosystem? 

We’re like the information booth at the airport. We are a hub that connects people and organizations, including scientists, intellectual property and product development experts, venture capitalists, pharmaceutical companies, and others seeking opportunities in life sciences. 

We direct people to the resources they need, whether that’s in patient care, research or innovation. BioHouston is community-driven and not connected to any one institution. We offer an efficient way to learn about what resources and opportunities exist.

BioHouston does talent matchmaking, helping companies find newly-minted grads, for example. We can connect start-ups with accelerator programs, office or lab space. Insurance companies, banks, payroll companies and lab supply sellers come to us for introductions when they are looking for business development opportunities in the life sciences community. 

How do you think COVID-19 will affect the life sciences ecosystem? 

I think it’s been interesting to see how COVID has reshaped and reframed how people interact. So much U.S. life sciences activity is based on the east and west coasts. But now, location isn’t a factor. A venture capitalist can do a Zoom call, or a top scientist can present at our virtual Texas Life Sciences Forum – without leaving home. As we all get more comfortable with virtual technology platforms, Houston’s life sciences ecosystem will benefit.  

We have several Houston area contract manufacturers producing SARS-CoV-2 vaccines for multiple pharma companies. We also have several local companies developing their own novel COVID-19-related treatments. And of course, on the patient care side, the Texas Medical Center has played a tremendous role during the pandemic. We will continue to see great leadership from TMC and our local academic and research institutions.

How can members of the business community support BioHouston?

Because of the pandemic and limits on bringing people together, we have had to reschedule two events the business community may recognize – our Women in Science with Excellence (WISE) event and our Chili Cook-off. So watch for news about those events in 2021. We welcome new members and community partners to join our ranks. We also invite business leaders to follow BioHouston on LinkedIn, to stay abreast of our work in the community.

Learn more about Houston's life science industry. 

Related News

Economic Development

San Jacinto College and CellReady Launch Program to Accelerate Cell Therapy Workforce Development

12/17/24
PASADENA, Texas – The San Jacinto College Center for Biotechnology has partnered with CellReady, a privately held cell therapy contract development and manufacturing organization, to launch an innovative, fast-track training curriculum for new hires in biomanufacturing. This four-week program is designed to significantly shorten onboarding time for manufacturing associates, providing them with concentrated and rigorous hands-on training to jumpstart their readiness to work in advanced cell therapy manufacturing.  Over the course of the program, trainees undergo 160 hours of both theoretical and practical, hands-on learning that cover the fundamentals of biomanufacturing through the operation of advanced workflows. The curriculum prepares new hires for the production of cell therapies, a cutting-edge cancer treatment, using the G-Rex cell production platform. The training, which took place at CellReady’s manufacturing site in Houston, was delivered by San Jacinto College Biotechnology faculty members, in collaboration with CellReady’s training team. “To our knowledge, this is the first collaboration of its kind between a community college and a cell therapy manufacturer to develop an intensive onboarding curriculum tailored specifically for cell therapy manufacturing technicians,” said Dr. Chris Wild, San Jacinto College assistant vice chancellor of biotechnology. “Together with CellReady, we’ve created a path to rapidly train professionals with advanced, hands-on techniques, using the G-Rex cell production platform, which is widely used in the industry today.”  This joint initiative provides clear benefits to all stakeholders. For San Jacinto College, it underscores the institution’s commitment to meeting industry needs with innovative, real-world training.  CellReady gains a streamlined, effective approach to onboarding that enables new technicians to make an immediate impact post-training. At the conclusion of the program, trainees are equipped with the skills and knowledge needed to manufacture cell therapies. Dr. Ignacio Nunez, CellReady’s chief operating officer, was impressed with the training provided and the speed that employees were able to grasp the critical components of the manufacturing process, stating “Thanks to the training program developed and delivered by San Jacinto College and CellReady, we were able to provide our new hires with the essential knowledge and skills to work in a GMP environment. In collaboration with San Jacinto College, we have debottlenecked operator qualification and made great strides toward our mission of bringing more of these life-saving therapies to patients one G-Rex at a time.” “This program not only equips new team members with qualifiable skills to contribute immediately upon completion of the training program, but it also sets a new standard for how training can be delivered in a highly regulated field,” said Dr. Nicole Bradley, program director for the Center for Biotechnology. The program’s success has inspired plans for additional training sessions to onboard future manufacturing professionals at CellReady, further strengthening the relationship between San Jacinto College and CellReady. The training curriculum for cell therapy developed in collaboration with this industry leader will be available as a program offering through the San Jacinto Center for Biotechnology. About CellReady CellReady is the world's first and only G-Rex centric contract development and manufacturing organization (CDMO) specializing in G-Rex based cell and gene-modified cell therapy development and manufacturing. The company offers a wide range of services to support the development and commercialization of these therapies. CellReady's mission is to create hope for cancer patients, one G-Rex® process at a time. About San Jacinto College Surrounded by monuments of history, evolving industries, maritime enterprises of today, and the space age of tomorrow, San Jacinto College has served the people of East Harris County, Texas, since 1961. The College is one of the top 10 community colleges in the nation as designated by the Aspen Institute and was named an Achieving the Dream Leader College of Distinction in 2020. The College is a Hispanic-Serving Institution that spans five campuses, serving approximately 45,000 credit and non-credit students annually. It offers more than 200 degrees and certificates across eight major areas of study that put students on a path to transfer to four-year institutions or enter the workforce. The College is fiscally sound, holding bond ratings of AA+ by Standard & Poor’s and Aa2 by Moody’s.
Read More
Construction

Construction Tech Pioneer Mercator.ai Launches AI- Powered Business Development Platform in Houston's $25B Commercial Construction Market

12/6/24
[PRESS RELEASE] Construction projects are won through relationships, 65% of business developers' time is spent searching for leads. Mercator.ai brings its visionary AI business development platform to Houston, flipping that equation for Texas's largest construction market.   HOUSTON, TX (December 2024) -- Mercator.ai, the leading AI-powered business development platform for commercial construction, announced its expansion into the Houston market. This strategic move follows the company's successful launch in Austin earlier this year and marks another milestone in Mercator's ambitious Texas growth strategy.   Houston's robust commercial construction sector, a cornerstone of Texas's $22.3 billion construction industry, represents a strategic growth opportunity for Mercator.ai's innovative construction technology platform. The expansion enables Houston-based general contractors, subcontractors, and construction service providers to access real-time insight into upcoming project opportunities earlier than ever before.    "Houston's sprawling growth and increasing competitive landscape make it ripe for innovation and the perfect next step in our Texas expansion," said Chloe Smith, CEO & Co-founder of Mercator.ai. "Our platform transforms how construction professionals discover and qualify new projects, reducing weeks of business development research into minutes and enabling teams to start building mutually profitable relationships at the earliest possible project stage."   The platform's expansion into Houston includes:  Access to relationship mapping and contact information for key project stakeholders Complete coverage of private and public commercial and industrial construction projects across the City of Houston Real-time monitoring of early project signals including land and real estate transactions, permitting, and development proposals Houston construction firms using Mercator.ai gain measurable advantages in project pursuit efficiency. Early adopters report reduction in pursuit research time by over 50%, and increase in lead identification - identifying five times as many qualified opportunities in the same time traditionally spent in a single networking meeting. The platform's early project detection capabilities are especially valuable in Houston's fast-moving market, where being first to the opportunity often means a higher probability of winning the work.   Mercator.ai's expansion into Houston builds on the company's growing Texas presence, with plans to actively participate in key industry events and construction community initiatives throughout 2024 and 2025. The company will maintain its commitment to relationship-based business development while providing contractors with the digital tools to enhance their project and relationship intelligence.   "Houston's construction community is known for innovation and relationship-building," said Chloe Smith, CEO of Mercator.ai. "We're excited to offer Houston contractors a 7-day free trial of our platform, allowing teams to experience firsthand how early project detection can optimize their most limited resource - time."   General contractors and construction professionals interested in exploring Mercator's early project detection platform can visit www.mercator.ai to start their free trial.   About Mercator.ai  Mercator.ai is an AI-powered relationship-based business development software for General Contractors, Sub-Contractors, Suppliers, and Construction Service Providers. It is the fastest and most accurate way to find early, viable construction opportunities. From commercial to industrial projects, Mercator.ai provides 100% coverage of public and private opportunities from concept to completion in real-time. Empower your teams with real-time insights to develop targeted business development strategies in less time. 
Read More

Related Events

Executive Partners